Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6230399rdf:typepubmed:Citationlld:pubmed
pubmed-article:6230399lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:6230399lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:6230399lifeskim:mentionsumls-concept:C0221284lld:lifeskim
pubmed-article:6230399lifeskim:mentionsumls-concept:C0343900lld:lifeskim
pubmed-article:6230399lifeskim:mentionsumls-concept:C0439659lld:lifeskim
pubmed-article:6230399lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:6230399pubmed:issue4lld:pubmed
pubmed-article:6230399pubmed:dateCreated1984-4-24lld:pubmed
pubmed-article:6230399pubmed:abstractTextDisseminated infection with Histoplasma capsulatum stimulates the production of a suppressor factor (SF-H) by spleen cells from C3H/HeJ mice and a helper factor (HF-H) by spleen cells from C57BL/6 mice. In the present study these disparate immunoregulatory factors were analyzed in detail with regard to: a) the surface phenotype of the cells that produce SF-H and HF-H; b) the role of accessory cells in the production of these factors; and c) the surface phenotype of the target cells activated by SF-H and HF-H. Treatment of spleen cells from Histoplasma-infected C3H/HeJ mice with anti-Thy-1.2 plus complement (C) or with anti-Ly-2 plus C or with anti-I-Jk antiserum plus C abolished production of SF-H. Conversely, generation of HF-H by spleen cells from C57BL/6 mice was abrogated by treatment with either anti-Thy-1.2 plus C or with anti-Ly-1 plus C. Thus, a Thy-1.2+, Ly-2+, I-J+ T cell releases SF-H, and a Thy-1.2+, Ly-1+ T cell secretes HF-H. Production of SF-H and HF-H by splenic T cells was reduced markedly by depletion of macrophages (M phi); readdition of 1% syngeneic, plastic-adherent splenocytes from normal or infected mice to M phi-depleted, splenic T cell cultures of either strain restored the capacity to generate immunoregulatory factors. Furthermore, adherent splenocytes from normal or infected mice liberated a factor or factors that enhanced production of both SF-H and HF-H. Kinetic studies demonstrated that activation of normal spleen cells required at least 48 hr of exposure to SF-H or HF-H. Both factors failed to activate splenocytes pretreated with anti-Thy-1.2 plus C. Spleen cells from C3H/HeJ mice depleted of Ly-1+, Ly-2+, or I-J+ cells and exposed to SF-H did not demonstrate suppressor activity, whereas Ly-1-depleted splenocytes from C57BL/6 mice exposed to HF-H failed to exert helper activity. Therefore, the target of SF-H is a Thy-1.2+, Ly-1+2+, I-J+ T cell, and the target of HF-H is a Thy-1.2+, Ly-1+ T cell.lld:pubmed
pubmed-article:6230399pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:languageenglld:pubmed
pubmed-article:6230399pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6230399pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6230399pubmed:statusMEDLINElld:pubmed
pubmed-article:6230399pubmed:monthAprlld:pubmed
pubmed-article:6230399pubmed:issn0022-1767lld:pubmed
pubmed-article:6230399pubmed:authorpubmed-author:WatsonS RSRlld:pubmed
pubmed-article:6230399pubmed:authorpubmed-author:BullockW EWElld:pubmed
pubmed-article:6230399pubmed:authorpubmed-author:DeepeG SGSJrlld:pubmed
pubmed-article:6230399pubmed:issnTypePrintlld:pubmed
pubmed-article:6230399pubmed:volume132lld:pubmed
pubmed-article:6230399pubmed:ownerNLMlld:pubmed
pubmed-article:6230399pubmed:authorsCompleteYlld:pubmed
pubmed-article:6230399pubmed:pagination2064-71lld:pubmed
pubmed-article:6230399pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:meshHeadingpubmed-meshheading:6230399-...lld:pubmed
pubmed-article:6230399pubmed:year1984lld:pubmed
pubmed-article:6230399pubmed:articleTitleCellular origins and target cells of immunoregulatory factors in mice with disseminated histoplasmosis.lld:pubmed
pubmed-article:6230399pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6230399pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6230399pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6230399lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6230399lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6230399lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6230399lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6230399lld:pubmed